-
DE30 back above 16,000 barrier
-
Markets extend rally after US CPI report
-
KeyBanc analysts raise recommendation on Gerresheimer (GXI.DE) shares
-
Jefferies bullish on European semiconductor market
Wednesday's session on European stock markets brings an improvement in investor sentiment. At the moment, all major companies in most sectors of the economy are posting clear rises. The bullish sentiment was briefly reinforced after the reading of the US CPI inflation report, the dynamics of which turned out to be lower than the analytical consensus.
The next item on the macro calendar to watch out for today will be the BoC's interest rate decision.
Start investing today or test a free demo
Create account Try a demo Download mobile app Download mobile appThe mood in Europe during Wednesday's trading session is clearly positive. All sectors are recording gains today. Source: xStation 5
German DE30 futures are gaining nearly 0.9% during today's session and are testing the resistance level set by the 16,000 point zone. Source: xStation 5
News
Goldman Sachs initiated analyst coverage on shares of Fresenius Medical (FME.DE) with a 'buy' rating and a target price of €56. The company's shares are up nearly 5% today.
Source: xStation 5
Analysts at KeyBanc recommended Gerresheimer (GXI.DE) shares, stating that the company's leading position is not reflected in the share price. The KeyBanc analyst writes that Gerresheimer's position in drug delivery technology is not reflected in a 60% discount to competitors Stevanato and West Pharmaceutical. The institution has given the company an "overweight" rating with a target price of €200 (+86% from yesterday's closing levels).
Source: xStation 5
Jefferies raises ratings and target prices for European semiconductor companies. ASML (ASML.NL) target price raised to €950 vs previous €700, Aixtron (AIXA.DE) to €45 vs previous €40, Infineon (IFX.DE) to €40 vs previous €28, STMicro (STM.FR) to €46 vs previous €33.
KBW downgraded its recommendation on Deutsche Bank (DBK.DE) shares to a "market perform" rating Target price of €14.
The largest percentage changes in individual companies of the DAX index. Source: Bloomberg
Information from individual companies in the DAX index. Source: Bloomberg
This content has been created by XTB S.A. This service is provided by XTB S.A., with its registered office in Warsaw, at Prosta 67, 00-838 Warsaw, Poland, entered in the register of entrepreneurs of the National Court Register (Krajowy Rejestr Sądowy) conducted by District Court for the Capital City of Warsaw, XII Commercial Division of the National Court Register under KRS number 0000217580, REGON number 015803782 and Tax Identification Number (NIP) 527-24-43-955, with the fully paid up share capital in the amount of PLN 5.869.181,75. XTB S.A. conducts brokerage activities on the basis of the license granted by Polish Securities and Exchange Commission on 8th November 2005 No. DDM-M-4021-57-1/2005 and is supervised by Polish Supervision Authority.